nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—chronic obstructive pulmonary disease	0.513	1	CbGaD
Sucralfate—FGB—respiratory system—chronic obstructive pulmonary disease	0.0126	0.148	CbGeAlD
Sucralfate—FGG—lung—chronic obstructive pulmonary disease	0.00864	0.102	CbGeAlD
Sucralfate—EGF—respiratory system—chronic obstructive pulmonary disease	0.00785	0.0927	CbGeAlD
Sucralfate—Venous thrombosis—Aminophylline—chronic obstructive pulmonary disease	0.00732	0.123	CcSEcCtD
Sucralfate—EGF—connective tissue—chronic obstructive pulmonary disease	0.00691	0.0816	CbGeAlD
Sucralfate—FGB—lung—chronic obstructive pulmonary disease	0.00667	0.0787	CbGeAlD
Sucralfate—Fluid overload—Aminophylline—chronic obstructive pulmonary disease	0.00635	0.107	CcSEcCtD
Sucralfate—EGF—smooth muscle tissue—chronic obstructive pulmonary disease	0.00632	0.0746	CbGeAlD
Sucralfate—EGF—trachea—chronic obstructive pulmonary disease	0.0058	0.0685	CbGeAlD
Sucralfate—FGA—lung—chronic obstructive pulmonary disease	0.00571	0.0674	CbGeAlD
Sucralfate—FGF2—bronchus—chronic obstructive pulmonary disease	0.0057	0.0673	CbGeAlD
Sucralfate—FGF2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00558	0.0659	CbGeAlD
Sucralfate—FGF2—trachea—chronic obstructive pulmonary disease	0.00512	0.0604	CbGeAlD
Sucralfate—Fluid overload—Salbutamol—chronic obstructive pulmonary disease	0.00456	0.0769	CcSEcCtD
Sucralfate—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.00453	0.0763	CcSEcCtD
Sucralfate—Lung disorder—Formoterol—chronic obstructive pulmonary disease	0.00425	0.0716	CcSEcCtD
Sucralfate—Lung disorder—Arformoterol—chronic obstructive pulmonary disease	0.00425	0.0716	CcSEcCtD
Sucralfate—EGF—lung—chronic obstructive pulmonary disease	0.00417	0.0492	CbGeAlD
Sucralfate—Lung disorder—Salbutamol—chronic obstructive pulmonary disease	0.00401	0.0676	CcSEcCtD
Sucralfate—FGF2—lung—chronic obstructive pulmonary disease	0.00368	0.0434	CbGeAlD
Sucralfate—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00333	0.0561	CcSEcCtD
Sucralfate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.0354	CcSEcCtD
Sucralfate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.0236	CcSEcCtD
Sucralfate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.0224	CcSEcCtD
Sucralfate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.0223	CcSEcCtD
Sucralfate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.0188	CcSEcCtD
Sucralfate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0181	CcSEcCtD
Sucralfate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0181	CcSEcCtD
Sucralfate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00107	0.018	CcSEcCtD
Sucralfate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.018	CcSEcCtD
Sucralfate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00105	0.0177	CcSEcCtD
Sucralfate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00104	0.0176	CcSEcCtD
Sucralfate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.0171	CcSEcCtD
Sucralfate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.017	CcSEcCtD
Sucralfate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.0143	CcSEcCtD
Sucralfate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000848	0.0143	CcSEcCtD
Sucralfate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00083	0.014	CcSEcCtD
Sucralfate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.0135	CcSEcCtD
Sucralfate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000581	0.00979	CcSEcCtD
Sucralfate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00711	CcSEcCtD
Sucralfate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000419	0.00707	CcSEcCtD
Sucralfate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00562	CcSEcCtD
Sucralfate—EGF—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	8.25e-05	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	8.15e-05	0.000238	CbGpPWpGaD
Sucralfate—EGF—Immune System—TLR2—chronic obstructive pulmonary disease	8.11e-05	0.000236	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	8.08e-05	0.000236	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.06e-05	0.000235	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	7.97e-05	0.000232	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	7.97e-05	0.000232	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—KL—chronic obstructive pulmonary disease	7.95e-05	0.000232	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.9e-05	0.00023	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.9e-05	0.00023	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.9e-05	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	7.84e-05	0.000229	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.8e-05	0.000228	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.74e-05	0.000226	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.74e-05	0.000226	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.72e-05	0.000225	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	7.65e-05	0.000223	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—ALB—chronic obstructive pulmonary disease	7.64e-05	0.000223	CbGpPWpGaD
Sucralfate—EGF—Immune System—KL—chronic obstructive pulmonary disease	7.62e-05	0.000222	CbGpPWpGaD
Sucralfate—EGF—Disease—HDAC2—chronic obstructive pulmonary disease	7.57e-05	0.000221	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.51e-05	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	7.49e-05	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	7.48e-05	0.000218	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	7.47e-05	0.000218	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	7.47e-05	0.000218	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	7.45e-05	0.000217	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.44e-05	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	7.42e-05	0.000216	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	7.38e-05	0.000215	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	7.36e-05	0.000215	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.32e-05	0.000213	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NOS3—chronic obstructive pulmonary disease	7.3e-05	0.000213	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.29e-05	0.000213	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.29e-05	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	7.27e-05	0.000212	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.26e-05	0.000212	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.25e-05	0.000211	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.15e-05	0.000209	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.15e-05	0.000209	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS2—chronic obstructive pulmonary disease	7.05e-05	0.000206	CbGpPWpGaD
Sucralfate—EGF—Disease—KL—chronic obstructive pulmonary disease	7.04e-05	0.000205	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	6.94e-05	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	6.94e-05	0.000203	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	6.94e-05	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	6.88e-05	0.000201	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	6.82e-05	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	6.79e-05	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.66e-05	0.000194	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.65e-05	0.000194	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.53e-05	0.000191	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.53e-05	0.00019	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.51e-05	0.00019	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.51e-05	0.00019	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.5e-05	0.00019	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—EGFR—chronic obstructive pulmonary disease	6.43e-05	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	6.41e-05	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	6.4e-05	0.000187	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—chronic obstructive pulmonary disease	6.37e-05	0.000186	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—chronic obstructive pulmonary disease	6.37e-05	0.000186	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.29e-05	0.000183	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	6.24e-05	0.000182	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.22e-05	0.000182	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	6.21e-05	0.000181	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	6.15e-05	0.000179	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD8A—chronic obstructive pulmonary disease	6.14e-05	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	6.13e-05	0.000179	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.04e-05	0.000176	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	6.03e-05	0.000176	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	5.96e-05	0.000174	CbGpPWpGaD
Sucralfate—FGA—Disease—SERPINE1—chronic obstructive pulmonary disease	5.93e-05	0.000173	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.92e-05	0.000173	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.92e-05	0.000173	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.81e-05	0.00017	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.81e-05	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	5.76e-05	0.000168	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—chronic obstructive pulmonary disease	5.74e-05	0.000168	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	5.73e-05	0.000167	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERBB3—chronic obstructive pulmonary disease	5.71e-05	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	5.7e-05	0.000166	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.7e-05	0.000166	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.7e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.69e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CRP—chronic obstructive pulmonary disease	5.68e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—chronic obstructive pulmonary disease	5.67e-05	0.000165	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS3—chronic obstructive pulmonary disease	5.67e-05	0.000165	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.49e-05	0.00016	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TLR4—chronic obstructive pulmonary disease	5.44e-05	0.000159	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.41e-05	0.000158	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	5.34e-05	0.000156	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—chronic obstructive pulmonary disease	5.34e-05	0.000156	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	5.34e-05	0.000156	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.31e-05	0.000155	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.31e-05	0.000155	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.3e-05	0.000155	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.3e-05	0.000154	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.3e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	5.29e-05	0.000154	CbGpPWpGaD
Sucralfate—EGF—Disease—ERBB3—chronic obstructive pulmonary disease	5.28e-05	0.000154	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.27e-05	0.000154	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.26e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	5.24e-05	0.000153	CbGpPWpGaD
Sucralfate—EGF—Immune System—CRP—chronic obstructive pulmonary disease	5.22e-05	0.000152	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	5.22e-05	0.000152	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	5.14e-05	0.00015	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TLR2—chronic obstructive pulmonary disease	5.13e-05	0.00015	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.06e-05	0.000148	CbGpPWpGaD
Sucralfate—EGF—Immune System—TLR4—chronic obstructive pulmonary disease	5.01e-05	0.000146	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.94e-05	0.000144	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.93e-05	0.000144	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.87e-05	0.000142	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.83e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KL—chronic obstructive pulmonary disease	4.82e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Disease—HDAC2—chronic obstructive pulmonary disease	4.79e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	4.73e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	4.73e-05	0.000138	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.68e-05	0.000137	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.64e-05	0.000135	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.64e-05	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.59e-05	0.000134	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.55e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Disease—KL—chronic obstructive pulmonary disease	4.45e-05	0.00013	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS2—chronic obstructive pulmonary disease	4.4e-05	0.000128	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.28e-05	0.000125	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—chronic obstructive pulmonary disease	4.26e-05	0.000124	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.24e-05	0.000124	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.22e-05	0.000123	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.16e-05	0.000121	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.16e-05	0.000121	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	4.09e-05	0.000119	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.06e-05	0.000119	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.05e-05	0.000118	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.02e-05	0.000117	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—chronic obstructive pulmonary disease	3.98e-05	0.000116	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.97e-05	0.000116	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.97e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD8A—chronic obstructive pulmonary disease	3.89e-05	0.000113	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.78e-05	0.00011	CbGpPWpGaD
Sucralfate—FGA—Disease—TGFB1—chronic obstructive pulmonary disease	3.75e-05	0.000109	CbGpPWpGaD
Sucralfate—EGF—Disease—SERPINE1—chronic obstructive pulmonary disease	3.7e-05	0.000108	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.69e-05	0.000108	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—chronic obstructive pulmonary disease	3.67e-05	0.000107	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—chronic obstructive pulmonary disease	3.64e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB3—chronic obstructive pulmonary disease	3.62e-05	0.000105	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.61e-05	0.000105	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.59e-05	0.000105	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.56e-05	0.000104	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS3—chronic obstructive pulmonary disease	3.54e-05	0.000103	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.000103	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.52e-05	0.000103	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.52e-05	0.000103	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.42e-05	9.99e-05	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.4e-05	9.93e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.39e-05	9.9e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.35e-05	9.79e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB3—chronic obstructive pulmonary disease	3.34e-05	9.74e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CRP—chronic obstructive pulmonary disease	3.31e-05	9.64e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.31e-05	9.64e-05	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.28e-05	9.56e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.28e-05	9.55e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1B—chronic obstructive pulmonary disease	3.26e-05	9.51e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.25e-05	9.49e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.25e-05	9.48e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.25e-05	9.47e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.19e-05	9.29e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.18e-05	9.29e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.18e-05	9.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TLR4—chronic obstructive pulmonary disease	3.17e-05	9.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.12e-05	9.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.12e-05	9.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.06e-05	8.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.96e-05	8.64e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.92e-05	8.51e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.91e-05	8.49e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.88e-05	8.4e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.86e-05	8.34e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.86e-05	8.34e-05	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—chronic obstructive pulmonary disease	2.82e-05	8.24e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS2—chronic obstructive pulmonary disease	2.78e-05	8.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.7e-05	7.87e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.68e-05	7.81e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.63e-05	7.66e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.62e-05	7.65e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.62e-05	7.65e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.59e-05	7.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2.59e-05	7.56e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.57e-05	7.5e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.57e-05	7.5e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.57e-05	7.5e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.54e-05	7.41e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—chronic obstructive pulmonary disease	2.48e-05	7.24e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.48e-05	7.22e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.36e-05	6.88e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.36e-05	6.87e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.35e-05	6.85e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—SERPINE1—chronic obstructive pulmonary disease	2.34e-05	6.84e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—chronic obstructive pulmonary disease	2.34e-05	6.82e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.34e-05	6.82e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.33e-05	6.78e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—chronic obstructive pulmonary disease	2.29e-05	6.69e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.28e-05	6.66e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.25e-05	6.56e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—chronic obstructive pulmonary disease	2.24e-05	6.53e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.2e-05	6.43e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.2e-05	6.41e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.16e-05	6.31e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.16e-05	6.3e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.16e-05	6.3e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.1e-05	6.12e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.09e-05	6.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—chronic obstructive pulmonary disease	2.07e-05	6.05e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—chronic obstructive pulmonary disease	2.06e-05	6.02e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.02e-05	5.89e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.99e-05	5.8e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.98e-05	5.77e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.98e-05	5.77e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—chronic obstructive pulmonary disease	1.91e-05	5.57e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.78e-05	5.2e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.77e-05	5.15e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—chronic obstructive pulmonary disease	1.76e-05	5.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.74e-05	5.08e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.72e-05	5.02e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.69e-05	4.92e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.64e-05	4.79e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.64e-05	4.78e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.61e-05	4.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—chronic obstructive pulmonary disease	1.57e-05	4.58e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.57e-05	4.58e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.57e-05	4.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—chronic obstructive pulmonary disease	1.48e-05	4.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—chronic obstructive pulmonary disease	1.45e-05	4.23e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.45e-05	4.22e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.39e-05	4.06e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.35e-05	3.93e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.26e-05	3.67e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.23e-05	3.6e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.21e-05	3.54e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—chronic obstructive pulmonary disease	1.21e-05	3.52e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-05	3.52e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.19e-05	3.47e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.13e-05	3.29e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—chronic obstructive pulmonary disease	1.12e-05	3.25e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.11e-05	3.25e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.11e-05	3.23e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	3.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.04e-05	3.02e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.02e-05	2.96e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	9.18e-06	2.68e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.53e-06	2.49e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.81e-06	2.28e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.83e-06	1.99e-05	CbGpPWpGaD
